Finance entity
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention India, the most common co-covered peer. The tracked stories average 4 original sources each. National Board of Pharmaceuticals and Poisons appears in 1 tracked Finance story from July 28, 2026.
Last mentioned: Jul 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention India, the most common co-covered peer. The tracked stories average 4 original sources each. National Board of Pharmaceuticals and Poisons appears in 1 tracked Finance story from July 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering National Board of Pharmaceuticals and Poisons. Shared-story counts are live from our verified record — not editorial picks.
Post-conflict Sudan is courting Indian direct investment in pharma and healthcare, offering a frontier market play with an established 51% import dominance. The roundtable highlights the intersection of development finance and private capital.
National Board of Pharmaceuticals and Poisons is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
